A FitEyes member asked:
I wonder if anyone of you has ever tried Rescula. This is a new product for glaucoma.
It’s actually old
The FDA approved Rescula in 2000 for the treatment of open-angle
glaucoma and ocular hypertension. The drug was taken off the market in
the United States in 2005 (apparently for commercial reasons). But the
commercialization rights were licensed in 2009 to Sucampo
Pharmaceutials, Inc. Sucampo then submitted a supplemental New Drug
Application to the FDA and relaunched the product.
Filed Under (tags):
Preservatives found in pharmaceutical products are a group of chemical substances added in multidose solutions to primarily reduce the risk of microbial contamination. Benzalkonium chloride, Polyquad, SofZia, and Purite are the common preservatives especially used in anti glaucoma agents. While SofZia and Purite are new preservatives that have been called vanishing preservatives, because they convert to nontoxic substances once in the eye, Benzalkonium chloride, on the other hand is the most common ophthalmic preservative.